FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40135211000001108: Retsevmo 40mg capsules (Eli Lilly and Company Ltd) 168 capsule 8 x 21 capsules (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Jan 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1937521000001116 Retsevmo 40mg capsules (Eli Lilly and Company Ltd) 168 capsule 8 x 21 capsules en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1937541000001114 Retsevmo 40mg capsules (Eli Lilly and Company Ltd) 168 capsule 8 x 21 capsules (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Retsevmo 40mg capsules (Eli Lilly and Company Ltd) 168 capsule 8 x 21 capsules Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Retsevmo 40mg capsules (Eli Lilly and Company Ltd) 168 capsule 8 x 21 capsules Has AMP Retsevmo 40mg capsules (Eli Lilly and Company Ltd) true Inferred relationship Existential restriction modifier
Retsevmo 40mg capsules (Eli Lilly and Company Ltd) 168 capsule 8 x 21 capsules Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Retsevmo 40mg capsules (Eli Lilly and Company Ltd) 168 capsule 8 x 21 capsules Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Retsevmo 40mg capsules (Eli Lilly and Company Ltd) 168 capsule 8 x 21 capsules Is a Selpercatinib 40mg capsules 168 capsule true Inferred relationship Existential restriction modifier
Retsevmo 40mg capsules (Eli Lilly and Company Ltd) 168 capsule 8 x 21 capsules VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Retsevmo 40mg capsules (Eli Lilly and Company Ltd) 168 capsule 8 x 21 capsules Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Retsevmo 40mg capsules (Eli Lilly and Company Ltd) 168 capsule 8 x 21 capsules VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Retsevmo 40mg capsules (Eli Lilly and Company Ltd) 168 capsule 8 x 21 capsules Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Retsevmo 40mg capsules (Eli Lilly and Company Ltd) 168 capsule 8 x 21 capsules Has specific active ingredient Selpercatinib true Inferred relationship Existential restriction modifier
Retsevmo 40mg capsules (Eli Lilly and Company Ltd) 168 capsule 8 x 21 capsules Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Retsevmo 40mg capsules (Eli Lilly and Company Ltd) 168 capsule 8 x 21 capsules Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Retsevmo 40mg capsules (Eli Lilly and Company Ltd) 168 capsule 8 x 21 capsules Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Retsevmo 40mg capsules (Eli Lilly and Company Ltd) 168 capsule 8 x 21 capsules Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start